Maximum quantity allowed is 999
请选择数量
CAS RN: 71125-38-7 | 產品號碼: M1959
產品規格
Appearance | White to Light yellow to Green powder to crystaline |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 96.0 % |
性質
熔點 | 255 °C |
GHS
圖形表示 |
![]() |
信號詞 | Danger |
危險性說明 | H301 : Toxic if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
RTECS # | DL0702000 |
運輸資料
UN編號 | UN2811 |
類別 | 6.1 |
包裝類別 | III |
HS編碼* | 2935.90-000 |
Application
Meloxicam: A Preferential Cyclooxygenase-2 (COX-2) Inhibitor
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID), and a preferential cyclooxygenase-2 (COX-2) inhibitor. The mechanism of action is mainly by inhibition of the enzyme COX in the arachidonic acid metabolism pathway, resulting in reduced prostaglandin synthesis. In theory, a drug that selectively inhibited COX-2 might block inflammation, pain, and fever produced by prostaglandins while reducing the side effects (gastric erosions and ulcers) associated with inhibition of COX-1. (The product is for research purpose only.)
References
- Meloxican: Influence on arachidonic acid metabolism: Part 1. In vitro findings
- Meloxican: Influence on arachidonic acid metabolism: Part II. In vivo findings
- Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1
- Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4’-isomer
- Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety (a review)
考研文獻
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。